Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples